Tectonic Therapeutic, Inc.
TECXNasdaqCIK 1681087HealthcareFiscal year ends Dec 31
Reports and events: 173 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-04-2907:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-123672 |
| 2019-04-2607:23 ET | DEF 14A | Proxy statementPeriod 2019-06-11 | 0001193125-19-120864 |
| 2019-03-2516:31 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001193125-19-085321 |
| 2019-03-2507:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-084287 |
| 2019-02-0609:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-028978 |
| 2019-01-2517:11 ET | SC 13D | Ownership report, active investor | 0001193125-19-017226 |
| 2019-01-2208:00 ET | 8-K | 8.01 Other events | 0001193125-19-013423 |
| 2019-01-1116:23 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-19-007398 |
| 2019-01-1118:12 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-19-006212 |
| 2019-01-0716:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-003876 |
| 2018-12-2116:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-18-356370 |
| 2018-11-1316:20 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001193125-18-325511 |
| 2018-11-1308:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-324912 |
| 2018-10-0107:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-288547 |
| 2018-09-2417:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-18-281353 |
| 2018-08-0908:09 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001193125-18-243527 |
| 2018-08-0908:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-243524 |
| 2018-07-0511:40 ET | SC 13D | Ownership report, active investor | 0001072613-18-000404 |
| 2018-06-2516:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-18-202460 |
| 2018-06-1806:11 ET | S-1/A | Registration statement, amended | 0001193125-18-194951 |
| 2018-06-1106:10 ET | S-1/A | Registration statement, amended | 0001193125-18-188630 |
| 2018-06-0108:41 ET | S-1/A | Registration statement, amended | 0001193125-18-181102 |
| 2018-05-2514:31 ET | S-1 | Registration statement | 0001193125-18-175024 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:21 ET. Listed shows no prices and gives no investment advice.